Peter D’Hoore


Peter D’hoore graduated as Pharmacist at the University of Leuven, Belgium in 1987 and was certified as an Industrial Pharmacist two years later.

Peter joined Janssen Pharmaceutica, Belgium in 1990. He has worked within International Quality Assurance and New Product Introductions (Operations) and is currently active in Small Molecule Pharmaceutical Development as CMC leader where he also manages an international group of CMC Leaders.  Peter was responsible for the CMC development and launch of several new products such as the long-acting injectable antipsychotics Risperdal® Consta®, Invega Sustenna®/Xeplion® and Invega Trinza®/ Trevicta®, as well as the oral solid formulations Invega® and Risperdal Quicklet®.